Bioliberty are a medtech start-up developing rehabilitation solutions for degenerative and traumatic conditions.
Bioliberty has raised $8.3M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
Bioliberty's investors include Hanna Capital SEZC, Archangels, Eos, Scottish Enterprise, Old College Capital.
Bioliberty is headquartered in Edinburgh, United Kingdom.
Bioliberty are a medtech start-up developing rehabilitation solutions for degenerative and traumatic conditions.
Bioliberty is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bioliberty — Funding & Investors." VCBacked, March 18, 2026, https://www.vcbacked.co/company/bioliberty. Accessed September 29, 2026.
VCBacked. (2026). Bioliberty — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/bioliberty
{{cite web |title=Bioliberty — Funding & Investors |url=https://www.vcbacked.co/company/bioliberty |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated